respiratori
syncyti
viru
rsv
import
viral
pathogen
caus
seriou
bronchiol
pneumonia
infant
young
children
worldwid
rsv
also
receiv
increas
recognit
import
caus
lower
respiratori
tract
ill
immunocompromis
patient
young
children
elderli
despit
import
rsv
respiratori
pathogen
licens
vaccin
current
avail
rsv
infect
immun
children
formalin
inactivatedrsv
firsv
vaccin
fail
protect
also
yield
enhanc
pulmonari
diseas
vaccin
infant
follow
rsv
infect
studi
balbc
mice
becom
use
model
rsv
pathogenesi
sinc
firsvenhanc
diseas
also
observ
vaccin
balbc
mice
like
augment
lung
diseas
develop
pulmonari
eosinophilia
attribut
excess
type
immun
respons
rsv
g
protein
one
major
protect
antigen
good
induc
strong
serum
mucos
neutral
antibodi
respons
also
singl
immunodomin
i
epitop
span
rsv
g
amino
acid
larg
induc
specif
subset
cell
previous
report
rsv
g
protein
fragment
span
amino
acid
residu
deliv
recombin
adenovir
vector
success
elicit
longterm
protect
immun
rsv
infect
mice
baculovirus
envelop
virus
possess
rodshap
nucleocapsid
doubl
strand
circular
dna
genom
packag
baculovirus
gener
util
vector
high
level
product
recombin
protein
could
also
employ
gene
transfer
mammalian
cell
sever
research
group
demonstr
vaccin
recombin
baculoviru
induc
highlevel
humor
cellmedi
immun
variou
antigen
suggest
baculoviru
could
use
vaccin
carrier
addit
report
immun
recombin
baculoviru
express
hemagglutinin
gene
influenza
viru
elicit
strong
innat
immun
respons
protect
mice
influenza
viru
challeng
moreov
known
baculovirusspecif
immun
mammal
might
interfer
action
baculovirusbas
vaccin
present
studi
recombin
baculoviru
display
rsv
g
protein
bacrsvg
construct
result
clearli
show
strong
humor
cellular
immun
respons
induc
intranas
administr
bacrsvg
mous
model
importantli
complet
protect
rsv
challeng
without
vaccineinduc
ill
observ
bacrsvgimmun
mice
suggest
vaccin
bacrsvg
could
util
prophylact
vaccin
regimen
rsv
infect
baculovirus
propag
spodoptera
frugiperda
insect
cell
use
serumfre
medium
invitrogen
rsv
strain
propag
cell
atcc
manassa
va
dulbecco
modifi
eagl
medium
life
technolog
gaithersburg
md
supplement
heatinactiv
fetal
calf
serum
mm
glutamin
mm
hepe
nonessenti
amino
acid
penicillin
streptomycin
titrat
infect
plaqu
assay
describ
elsewher
code
sequenc
rsv
g
protein
rsv
strain
amplifi
cdna
pcr
clone
ecor
xho
site
vector
fig
recombin
baculoviru
subsequ
gener
use
system
invitrogen
follow
manufactur
instruct
recombin
baculovirus
purifi
supernat
infect
insect
cell
wv
sucros
mm
nacl
mm
edta
rotor
beckman
usa
rpm
min
supernat
decant
pellet
resuspend
phosphatebuff
salin
pb
centrifug
h
rpm
viral
pellet
resuspend
pb
titrat
plaqu
assay
cell
femal
balbc
mice
purchas
charl
river
laboratori
inc
yokohama
japan
mice
kept
specificpathogenfre
condit
immun
mice
inocul
baculovirus
via
intranas
rout
immun
mice
lightli
anesthet
etherchloroform
inhal
pfu
bacrsvg
baccontrol
volum
appli
left
nostril
three
four
week
second
immun
mice
challeng
pfu
live
rsv
strain
anim
studi
perform
accord
guidelin
institut
anim
care
use
committe
approv
blood
obtain
retroorbit
plexu
heparin
capillari
tube
collect
eppendorf
tube
centrifug
serum
store
rsv
g
proteinspecif
antibodi
titer
immun
mice
measur
direct
enzymelink
immunosorb
assay
elisa
briefli
plate
coat
overnight
purifi
g
protein
fragment
dilut
pb
block
pb
contain
skim
milk
h
sera
ad
serial
dilut
incub
h
plate
wash
five
time
pb
contain
tween
incub
min
variou
dilut
horseradish
peroxidaseconjug
affinitypurifi
rabbit
antimous
total
igg
secondari
antibodi
zyme
laboratori
san
francisco
ca
plate
wash
five
time
develop
reaction
stop
analyz
nm
thermo
elisa
plate
reader
well
receiv
serum
use
calcul
cutoff
valu
lung
perfus
ml
pb
contain
uml
heparin
sigmaaldrich
st
loui
mo
right
ventricl
use
syring
fit
needl
lung
remov
place
rpmi
medium
supplement
glutamin
gentamicin
penicillin
g
fb
hyclon
logan
ut
tissu
process
steel
screen
obtain
singlecel
suspens
particul
matter
remov
passag
falcon
cell
strainer
bd
labwar
franklin
lake
nj
freshli
explant
bal
fluid
lung
cell
purifi
densiti
gradient
centrifug
stain
use
fluorochromeconjug
antibodi
antibodi
use
clone
clone
clone
antibodi
purchas
bd
pharmingen
san
diego
ca
stain
cell
fix
wtvol
paraformaldehyd
event
acquir
use
facscalibur
flow
cytomet
bd
bioscienc
san
diego
ca
enumer
number
cytokineproduc
cell
intracellular
cytokin
stain
perform
describ
elsewher
brief
freshli
explant
lung
lymphocyt
cultur
cultur
tube
cell
left
untreat
stimul
g
peptid
waickripnkkpg
incub
h
brefeldin
sigmaaldrich
ad
durat
cultur
period
facilit
intracellular
cytokin
accumul
cell
stain
surfac
marker
wash
fix
permeabil
fluorescenceactiv
cell
sorter
buffer
contain
saponin
sigmaaldrich
seoul
korea
stain
cytokin
antibodi
use
clone
dead
cell
exclud
basi
forward
side
light
scatter
pattern
data
collect
use
cellquest
softwar
bd
bioscienc
analyz
cellquest
winmdi
version
softwar
scripp
research
institut
la
jolla
ca
lung
supernat
also
collect
analysi
flowcytomix
ebiosci
accord
protocol
kit
contain
antibodi
bead
use
measur
cytokin
level
sampl
day
postchalleng
subset
mice
group
sacrif
tracheotomi
perform
lung
airway
wash
ml
pb
contain
fetal
bovin
serum
fb
collect
bronchoalveolar
lavag
bal
cell
use
measur
eosinophil
approxim
cell
bal
fluid
incub
min
antifc
receptor
antibodi
prevent
nonspecif
bind
next
cell
stain
specif
antibodi
final
concentr
antibodi
use
peconjug
antisiglecf
apcconjug
fitcconjug
antibodi
purchas
bd
pharmingen
san
diego
ca
stain
cell
fix
wtvol
paraformaldehyd
event
acquir
use
facscalibur
flow
cytomet
bd
bioscienc
san
diego
ca
four
five
day
rsv
challeng
subset
mice
euthan
lung
remov
eagl
modifi
essenti
medium
tissu
process
steel
screen
obtain
singlecel
suspens
particul
matter
remov
passag
cell
strainer
bd
labwar
franklin
lake
nj
supernat
collect
rsv
titer
supernat
measur
standard
plaqu
assay
subconflu
monolay
data
express
pfu
per
gram
lung
tissu
comparison
differ
conduct
use
unpair
twotail
student
test
differ
consid
statist
signific
p
valu
recombin
baculoviru
express
rsv
g
code
sequenc
control
polyhedrin
promot
bacrsvg
gener
use
bactobac
system
plasmid
shown
fig
examin
whether
bacrsvg
express
display
rsv
g
viru
particl
western
blot
analysi
perform
sucros
gradientpurifi
baculovirus
use
gspecif
monoclon
antibodi
specif
band
approxim
kda
kda
detect
purifi
bacrsvg
particl
baccontrol
viru
particl
fig
posit
control
purifi
rsv
particl
produc
cell
use
slightli
higher
molecular
weight
band
detect
fig
size
differ
might
due
differ
pattern
glycosyl
insect
cell
human
cell
investig
immunogen
bacrsvg
group
mice
immun
bacrsvg
baccontrol
pb
rsv
gspecif
antibodi
level
sera
immun
mice
week
prime
week
boost
determin
elisa
specif
antibodi
respons
bare
detect
group
mice
day
prime
data
shown
follow
booster
immun
howev
mean
titer
serum
antibodi
increas
significantli
group
mice
immun
bacrsvg
fig
secretori
iga
shown
directli
mediat
local
immun
aerial
pathogen
impli
import
role
antibodi
protect
upper
respiratori
tract
thu
effect
rsv
vaccin
develop
induct
secretori
iga
respiratori
mucos
surfac
critic
examin
whether
bacrsvg
vaccin
elicit
iga
respons
respiratori
tract
bronchoalveolar
lavag
bal
perform
day
rsv
challeng
level
iga
determin
rsvspecif
elisa
group
mice
immun
baccontrol
pb
exhibit
specif
iga
respons
wherea
bacrsvgimmun
mice
show
significantli
enhanc
level
specif
iga
respons
fig
result
suggest
intranas
immun
bacrsvg
effect
induc
rsv
gspecif
serum
igg
respiratori
iga
sinc
rsv
g
contain
iedrestrict
tcell
epitop
examin
whether
bacrsvg
immun
induc
specif
cell
end
bacrsvg
baccontrol
pb
immun
mice
challeng
rsv
cell
respons
evalu
day
challeng
measur
product
lung
lymphocyt
stimul
iedrestrict
g
epitop
peptid
ex
vivo
shown
fig
gspecif
detect
lung
bacrsvgimmun
group
gate
cell
averag
specif
cell
cell
observ
lung
baccontrol
pbsimmun
group
next
investig
whether
immun
bacrsvg
induc
cell
subset
bacrsvgvaccin
mice
show
increas
frequenc
gspecif
cell
lung
rsv
challeng
gate
cell
averag
fig
howev
level
cytokin
measur
multiplex
antibodybas
bead
assay
significantli
differ
lung
group
mice
fig
togeth
result
indic
mix
gspecif
respons
induc
bacrsvg
vaccin
determin
whether
bacrsvg
protect
efficaci
rsv
infect
mice
challeng
live
rsv
viru
four
week
booster
immun
activ
rsv
replic
lung
baccontrol
pb
immun
mice
immun
bacrsvg
prevent
detect
rsv
replic
lung
peak
infect
fig
interestingli
immun
baccontrol
result
partial
decreas
viral
replic
peak
might
due
nonspecif
innat
immun
induc
baculoviru
inocul
previous
report
intranas
administr
wildtyp
baculoviru
induc
strong
innat
immun
respons
provid
protect
lethal
challeng
influenza
viru
report
immun
vaccinia
viru
express
entir
rsv
g
glycoprotein
result
pulmonari
eosinophilia
follow
challeng
live
rsv
studi
indic
rsv
g
express
vaccin
possibl
develop
pulmonari
eosinophilia
determin
whether
intranas
immun
bacrsvg
potenti
eosinophilia
level
eosinophil
bal
fluid
immun
mice
examin
flow
cytometri
day
rsv
challeng
use
antibodi
siglecf
describ
previous
bacrsvgimmun
mice
higher
frequenc
bal
compar
baccontrol
pb
group
fig
p
level
eosinophil
influx
bacrsvg
immun
mice
rel
weak
total
bal
cell
result
suggest
intranas
bacrsvg
immun
bare
increas
risk
vaccineinduc
eosinophilia
evalu
rsvinduc
patholog
bacrsvg
immun
monitor
weight
loss
immunemic
rsv
challeng
follow
infect
live
rsv
signific
weight
loss
bacrsvgimmun
mice
fig
diseas
score
data
shown
taken
togeth
result
suggest
intranas
bacrsvg
vaccin
give
rise
protect
immun
absenc
subsequ
vaccineenhanc
diseas
develop
safe
effect
rsv
vaccin
mani
strategi
platform
appli
preclin
clinic
phase
mani
rsv
vaccin
candid
specifi
target
antigen
employ
two
envelop
protein
g
attach
protein
f
fusion
protein
antigen
known
induc
protect
immun
live
rsv
infect
howev
balbc
mous
model
immun
g
protein
express
recombin
vaccinia
viru
elicit
respons
respons
vaccineenhanc
diseas
thu
g
protein
fals
regard
bad
target
antigen
long
time
although
could
induc
strong
neutral
antibodi
respons
upon
immun
recent
suggest
g
protein
caus
vaccineenhanc
diseas
proper
balanc
rsvspecif
respons
rather
import
factor
control
safeti
efficaci
gtarget
rsv
vaccin
use
appropri
platform
andor
adjuv
balanc
could
achiev
gtarget
vaccin
exampl
recent
demonstr
mucos
immun
recombin
adenoviru
vaccin
express
core
domain
g
success
induc
protect
immun
without
vaccineinduc
diseas
baculoviru
recent
emerg
new
tool
vaccin
vector
develop
sinc
mani
advantag
vaccin
platform
first
baculoviru
use
overexpress
recombin
protein
insect
cell
neither
replicationcompet
pathogen
mammalian
cell
make
safer
vaccin
vector
mammalian
viral
vector
addit
baculovirusbas
vaccin
produc
insect
cell
contamin
lp
second
baculovirusbas
vaccin
possess
sever
advantag
upon
product
easi
manipul
rel
simpl
scaleup
high
titer
thirdli
preexist
vector
immun
baculoviru
mammal
enabl
baculoviru
escap
vector
neutral
preexist
immun
vivo
deliveri
lastli
baculoviru
abil
stimul
strong
innat
immun
exhibit
strong
adjuvant
previous
shown
inocul
wildtyp
baculoviru
alon
stimul
secret
inflammatori
cytokin
innat
immun
cell
confer
protect
lethal
viru
infect
mice
consist
report
intranas
inocul
control
baculoviru
also
provid
partial
protect
live
rsv
challeng
studi
fig
baculovirusmedi
stimul
innat
immun
might
associ
induct
type
interferon
mediat
pathway
thu
becom
evid
baculoviru
act
natur
adjuv
stimul
innat
immun
use
safe
effect
vaccin
carrier
data
demonstr
intranas
immun
bacrsvg
vaccin
induc
complet
protect
rsv
infect
associ
enhanc
respons
absenc
signific
respons
although
role
ctl
respons
rsv
clearanc
well
delin
role
respons
fulli
elucid
host
defens
rsv
cell
character
massiv
product
thought
contribut
autoimmun
diseas
also
play
crucial
role
host
defens
extracellular
bacteria
addit
effector
molecul
seem
necessari
suffici
protect
sever
viral
pathogen
exampl
recent
studi
report
cell
potent
cytolyt
vaccinia
virusinfect
cell
studi
cell
necessari
confer
protect
viral
infect
exhibit
cytotox
activ
clearanc
vaccinia
virusinfect
cell
mice
immun
recombin
vaccinia
viru
express
g
protein
rsv
vvg
exhibit
pulmonari
eosinophilia
induc
type
cytokin
challeng
rsv
infect
type
cytokin
thought
promot
eosinophil
infiltr
lung
rsvinfect
mice
may
contribut
immunopatholog
associ
vaccineenhanc
diseas
interestingli
show
level
cytokin
low
lung
bacrsvgimmun
mice
follow
rsv
challeng
significantli
differ
pb
control
group
sever
evid
suggest
neg
regul
cytokin
product
thu
induct
respons
bacrsvg
vaccin
may
attenu
develop
respons
furthermor
may
play
certain
role
immun
defens
lung
includ
augment
mucos
immun
deliveri
iga
igm
airway
lumen
though
exact
mechan
respons
induc
bacrsvg
vaccin
clear
gspecif
respons
may
associ
clearanc
rsv
lung
studi
need
elucid
exact
role
immun
rsv
infect
conclus
present
studi
demonstr
baculoviru
display
rsv
g
protein
bacrsvg
induc
antigenspecif
humor
cellular
immun
provid
protect
rsv
challeng
without
vaccineinduc
immunopatholog
thu
studi
provid
strong
evid
bacrsvg
vaccin
could
develop
mucos
rsv
vaccin
